DexCom, Inc. vs Virgin Galactic Holdings, Inc. — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while Virgin Galactic Holdings, Inc. trades at $3.29 (market cap $488.94M). The key difference: DexCom, Inc. is far larger — about 67.7× Virgin Galactic Holdings, Inc.'s market cap, and DexCom, Inc. is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| DXCM | SPCE | |
|---|---|---|
Market Cap | $33.08B | $488.94M |
Sector | Health | Industrials |
52-Week High | $89.53 | $7.52 |
52-Week Low | $54.84 | $2.17 |
Enterprise Value | $32.53B | $588.79M |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →